Tower Research Capital LLC (Trc) Bio Atla, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Atla, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,135 shares of BCAB stock, worth $2,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,135
Previous 17,871
71.27%
Holding current value
$2,516
Previous $24,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BCAB
# of Institutions
66Shares Held
17.5MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.23 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$923,7730.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$910,5060.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$428,2970.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $17.8M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...